Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leopold Sellner

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Human Gene Therapy|July 20, 2018
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T CellsSophia Stock, Jean-Marc Hoffmann, Maria-Luisa Schubert, et al.
Oncology Reports|June 24, 2021
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignanciesSanmei Wang, Leopold Sellner, Lei Wang, et al.
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
Cells|January 20, 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T CellsWenjie Gong, Lei Wang, Sophia Stock, et al.
Ebiomedicine|June 10, 2018
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-ImmunotherapyGeorg Gdynia, Tadeusz Robak, Jürgen Kopitz, et al.
Cancer Immunology, Immunotherapy : CII|June 10, 2019
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cellsWenjie Gong, Jean-Marc Hoffmann, Sophia Stock, et al.
Leukemia|May 15, 2020
Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependenciesMarina Lukas, Britta Velten, Leopold Sellner, et al.
International Journal of Cancer|July 20, 2020
Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patientsFuli Fan, Hyeon Joo Yoo, Sophia Stock, et al.
Cytotherapy|March 27, 2019
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cellsLei Wang, Wenjie Gong, Sanmei Wang, et al.
International Journal of Molecular Sciences|May 22, 2019
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell MalignanciesHyeon Joo Yoo, Yibin Liu, Lei Wang, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Human Gene Therapy|July 20, 2018
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T CellsSophia Stock, Jean-Marc Hoffmann, Maria-Luisa Schubert, et al.
Oncology Reports|June 24, 2021
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignanciesSanmei Wang, Leopold Sellner, Lei Wang, et al.
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
Cells|January 20, 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T CellsWenjie Gong, Lei Wang, Sophia Stock, et al.
Ebiomedicine|June 10, 2018
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-ImmunotherapyGeorg Gdynia, Tadeusz Robak, Jürgen Kopitz, et al.
Cancer Immunology, Immunotherapy : CII|June 10, 2019
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cellsWenjie Gong, Jean-Marc Hoffmann, Sophia Stock, et al.
Leukemia|May 15, 2020
Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependenciesMarina Lukas, Britta Velten, Leopold Sellner, et al.
International Journal of Cancer|July 20, 2020
Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patientsFuli Fan, Hyeon Joo Yoo, Sophia Stock, et al.
Cytotherapy|March 27, 2019
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cellsLei Wang, Wenjie Gong, Sanmei Wang, et al.
International Journal of Molecular Sciences|May 22, 2019
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell MalignanciesHyeon Joo Yoo, Yibin Liu, Lei Wang, et al.
Pageof 5